Reduced Ejection Fraction of the Systemic Right Ventricle and Severe Tricuspid Regurgitation: Medication or Surgery?
Anton V Minaev, Timur Y Danilov, Diana P Paraskevova, Vera I Dontsova, Inna I Trunina, Viktor B Samsonov, Sofya M Tsoy, Alexander S Voynov, Julia A Sarkisyan, Satoshi Akagi, Jin Young Song · 2025
Read Reduced Ejection Fraction of the Systemic Right Ventricle and Severe Tricuspid Regurgitation: Medication or Surgery? by Anton V Minaev, Timur Y Danilov, Diana P Paraskevova, Vera I Dontsova, Inna I Trunina, Viktor B Samsonov, Sofya M Tsoy, Alexander S Voynov, Julia A Sarkisyan, Satoshi Akagi, Jin Young Song (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12733829.txt.
Description
Anton Minaev and colleagues compared medicines and surgery for a swapped heart ventricle in 2025. Some hearts pump body blood with the right ventricle. That ventricle weakens over time badly. Its inlet valve also leaks severely. No proven drug standard exists here. Surgical replacement is the alternative path.
A stepwise combined approach was assessed. Modern heart failure drugs came first. Elective valve replacement followed for suitable patients. Ventricular function improved after optimisation. Surgery proved safe in that sequence. Significant leakage did not recur afterward. Pharmacotherapy belongs in management plans now. Timing surgery after drugs seems wise.
Catalog record
| CREATOR | Anton V Minaev, Timur Y Danilov, Diana P Paraskevova, Vera I Dontsova, Inna I Trunina, Viktor B Samsonov, Sofya M Tsoy, Alexander S Voynov, Julia A Sarkisyan, Satoshi Akagi, Jin Young Song |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |